What is CareDx's clinical studies?

CareDx (CDNA) reported clinical studies of $12.42M in Q1 2026.

How has CareDx's clinical studies changed year-over-year?

CareDx's clinical studies decreased by 25.6% year-over-year, from $16.7M to $12.42M.

What is the long-term trend for CareDx's clinical studies?

Over 5 years (2020 to 2025), CareDx's clinical studies has grown at a 12.9% compound annual growth rate (CAGR), from $6.73M to $12.36M.

CareDx CDNA Clinical studies

Other financials

Income statement

See full

Revenue$117.7M+39.0%

Operating income$1.2M+109%

Net income$2.8M+127%

EPS (diluted)$0.05+126%

Balance sheet

See full

Cash & equivalents$78.5M-12.1%

Total debt$24.5M-19.1%

Total equity$313.5M-17.3%

Total assets$411.1M-16.0%

Cash flow

See full

Operating cash flow$4.3M+116%

CapEx$3.8M+134%

Free cash flow$514.0K+102%

Valuation

See full

Market cap$1.4B+32.2%

Enterprise value$1.35B+34.6%

P/S3.4×+0.3×

Profitability

See full

Gross margin65.5%—

Operating margin-3.9%-18.3pp

Net margin-2%-19.9pp

FCF margin-0%0.0pp

Returns & leverage

See full

Return on equity-2.4%-21.9pp

Debt / equity0.1×0.0×

Current ratio3.4×-0.7×

Where this comes from

Reported directly by CareDx in its filing.

Tagged under the XBRL concept cdna:AccruedClinicalAndCostOfOtherStudiesCurrent.

The official record: CareDx’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about CareDx's clinical studies.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CareDx's clinical studies?: CareDx (CDNA) reported clinical studies of $12.42M in Q1 2026.
How has CareDx's clinical studies changed year-over-year?: CareDx's clinical studies decreased by 25.6% year-over-year, from $16.7M to $12.42M.
What is the long-term trend for CareDx's clinical studies?: Over 5 years (2020 to 2025), CareDx's clinical studies has grown at a 12.9% compound annual growth rate (CAGR), from $6.73M to $12.36M.